ILMNNasdaqLaboratory Analytical InstrumentsFiscal year ends January 3
ILLUMINA, INC.
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Jul 31, 2026
$262.66+0.12 (+0.05%)
Close on Oct 19, 2026
- Market cap
- $40.19B
- P/E (TTM)
- 48.8
- Dividend yield
- –
ILLUMINA, INC. revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Core Illumina | $4.49B | $4.39B | $4.34B | $4.29B | $4.28B | $4.32B | $4.33B | $4.33B | $4.35B | $4.42B | $4.44B | $4.41B | 100.0% | +4.9% |
| Sequencing | $4.12B | $4.03B | $3.99B | $3.92B | $3.92B | $3.96B | $3.99B | $4.01B | $4.05B | $4.12B | $4.11B | $4.07B | 91.6% | +5.1% |
| Microarray | $377.00M | $359.00M | $358.00M | $364.00M | $366.00M | $375.00M | $379.00M | $376.00M | $381.00M | $378.00M | $392.00M | $396.00M | 8.4% | +3.0% |
| GRAIL | – | – | $0 | $0 | $0 | $29.00M | $55.00M | $87.00M | $108.00M | $101.00M | $93.00M | $86.00M | – | – |
| Operating income | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Core Illumina | – | – | – | – | – | – | – | $1.33B | $853.00M | $526.00M | $552.00M | $589.00M | – |
| GRAIL | – | – | – | – | – | – | – | -$2.50B | -$3.52B | -$1.64B | -$1.62B | -$1.62B | – |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total product revenue | $3.82B | $3.75B | $3.71B | $3.66B | $3.64B | $3.66B | $3.66B | $3.64B | $3.67B | $3.74B | $3.79B | $3.78B | 84.9% | +4.7% |
| Consumables | $3.30B | $3.26B | $3.23B | $3.17B | $3.17B | $3.16B | $3.16B | $3.13B | $3.09B | $3.08B | $3.08B | $3.09B | 73.4% | +4.2% |
| Service | $677.00M | $647.00M | $634.00M | $631.00M | $640.00M | $678.00M | $716.00M | $750.00M | $762.00M | $752.00M | $717.00M | $687.00M | 15.1% | +5.8% |
| Instruments | $519.00M | $490.00M | $482.00M | $483.00M | $479.00M | $498.00M | $501.00M | $508.00M | $582.00M | $659.00M | $704.00M | $687.00M | 11.6% | +8.4% |
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China | $216.00M | $223.00M | $243.00M | $267.00M | $290.00M | $302.00M | $308.00M | $310.00M | $333.00M | $373.00M | $384.00M | $398.00M | 4.8% | -25.5% |
| Americas | – | – | $2.41B | $2.36B | $2.35B | $2.41B | $2.44B | $2.45B | $2.51B | $2.51B | $2.52B | $2.51B | – | – |
| Europe | – | – | $1.26B | $1.24B | $1.22B | $1.20B | $1.19B | $1.17B | $1.14B | $1.16B | $1.14B | $1.09B | – | – |
| Asia-Pacific, Middle East and Africa | – | – | $430.00M | $426.00M | $420.00M | $428.00M | $438.00M | $453.00M | $446.00M | $456.00M | $459.00M | $460.00M | – | – |
From the segment and revenue-disaggregation notes of Illumina's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.